Reynolds Lindsey, Ullman Christopher, Moore Michael, Isalan Mark, West Michelle J, Clapham Paul, Klug Aaron, Choo Yen
Gendaq Ltd., Sangamo Biosciences, Inc., 1-3 Burtonhole Lane, Mill Hill, London NW7 1AD, United Kingdom.
Proc Natl Acad Sci U S A. 2003 Feb 18;100(4):1615-20. doi: 10.1073/pnas.252770699. Epub 2003 Feb 6.
Zinc finger domains are small DNA-binding modules that can be engineered to bind desired target sequences. Functional transcription factors can be made from these DNA-binding modules, by fusion with an appropriate effector domain. In this study, eight three-zinc-finger proteins (ZFPs) that bound HIV-1 sequences in vitro were engineered into transcription repressors by linking them to the Krüppel-associated box (KRAB) repressor domain (KOX1). One protein, ZFP HIVB-KOX, which bound to a 9-bp region overlapping two Sp1 sites, was found to repress a Tat-activated 5' LTR cellular HIV-reporter assay to almost basal levels. A related six-finger protein, HIVBA'-KOX, was made to target all three Sp1 sites in the 5' LTR promoter and efficiently inhibited both basal and Tat-activated transcription in unstimulated and mitogen-stimulated T cells. In contrast, a combination of two unlinked three-finger ZFPs, HIVA'-KOX and HIVB-KOX, which bind over the same region of DNA, resulted in less effective repression. Finally, HIVBA'-KOX was tested for its capacity to block viral replication in a cellular infection assay using the HIV-1 HXB2 strain. This ZFP was found to inhibit HIV-1 replication by 75% compared with control constructs, thus demonstrating the potential of this approach for antiviral therapy.
锌指结构域是小型的DNA结合模块,可通过工程改造使其结合所需的靶序列。通过与适当的效应结构域融合,可利用这些DNA结合模块构建功能性转录因子。在本研究中,通过将8种在体外与HIV-1序列结合的三锌指蛋白(ZFPs)与Krüppel相关盒(KRAB)抑制结构域(KOX1)相连,将它们改造为转录抑制因子。发现一种与两个Sp1位点重叠的9碱基区域结合的蛋白ZFP HIVB-KOX,可将Tat激活的5' LTR细胞HIV报告基因检测抑制至几乎基础水平。一种相关的六指蛋白HIVBA'-KOX靶向5' LTR启动子中的所有三个Sp1位点,并在未刺激和有丝分裂原刺激的T细胞中有效抑制基础转录和Tat激活的转录。相比之下,结合在相同DNA区域上的两个不相连的三指ZFPs(HIVA'-KOX和HIVB-KOX)的组合,导致的抑制效果较差。最后,在使用HIV-1 HXB2株的细胞感染试验中测试了HIVBA'-KOX阻断病毒复制的能力。与对照构建体相比,发现这种ZFP可将HIV-1复制抑制75%,从而证明了这种方法在抗病毒治疗中的潜力。